{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T05:20:19Z","timestamp":1739251219088,"version":"3.37.0"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Beijing Municipal Administration of Hospitals\u2019 Youth Programme","award":["QMS20210206"],"award-info":[{"award-number":["QMS20210206"]}]},{"name":"Scientific Research Common Program of Beijing Municipal Commission of Education","award":["KM202210025014"],"award-info":[{"award-number":["KM202210025014"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Objectives<\/jats:title>\n<jats:p>To explore the potential influence of Sjogren\u2019s syndrome (SS) on thyroid cancer (TC).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>First, a literature data mining (LDM) approach was used to reconstruct functional pathways connecting SS and TC. A meta-analysis was then performed to examine the expression changes of genes mediated by SS using 16 TC case\/control expression datasets, with results validated through the TCGA\/GTEx dataset. Finally, gene set enrichment analysis (GSEA) and survival analysis using GEPIA2 were conducted on the significant genes.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Our findings indicate that SS may increase the risk of TC by activating 14 TC promoters (PDCD1, NTRK1, LGALS3, CD274, FOXP3, BCL2, CYP1A1, HMGB1, TGFB1, CCL2, PLA2G7, TFF3, LCN2, and CLDN1) and suppressing three TC inhibitors (MIR145, MIR30C1, and EP300). Four molecules (PLA2G7, TFF3, LCN2, and CLDN1) exhibited significant expression changes in TC patients (LFC &gt; 1 or &lt; -1; p &lt; 2.07E-04), which were confirmed in TCGA\/GTEx expression analysis. These results highlight three possible mechanisms\u2014the SS-PLA2G7-CCL2-TC pathway, the SS-LCN2-LGALS3-TC pathway, and the SS-CLDN1-BCL2-TC pathway\u2014that may explain how SS contributes to TC development. Enrichment analysis suggests that SS may affect TC prognosis by regulating leukocytes and tolerance induction. Survival analysis indicates that SS may enhance TC survival through the regulation of the CLDN1 and EGF pathways.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>LDM-based pathway analysis highlighted three genetic pathways through which SS may adversely affect TC progression, while SS may enhance TC survival via the CLDN1 and EGF pathways, highlighting the need for further research.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0318747","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T18:27:12Z","timestamp":1739212032000},"page":"e0318747","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Explore the possible influence of Sjogren\u2019s syndrome on thyroid cancer: A literature data mining and meta-analysis"],"prefix":"10.1371","volume":"20","author":[{"given":"Fanyong","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boxuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xixi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhen","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jugao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2509-4958","authenticated-orcid":true,"given":"Meng","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"issue":"7","key":"pone.0318747.ref001","first-page":"980","article-title":"Sjogren\u2019s syndrome.","volume":"20","author":"F Andre","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"pone.0318747.ref002","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8352.1","article-title":"Recent advances in primary Sjogren\u2019s syndrome.","volume":"5","author":"N Holdgate","year":"2016","journal-title":"F1000Res"},{"key":"pone.0318747.ref003","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sjogren syndrome.","volume":"2","author":"P Brito-Zeron","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"pone.0318747.ref004","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/rheumatology\/kei107","article-title":"Epidemiology of primary Sjogren\u2019s syndrome in north-west Greece, 1982\u20132003.","volume":"45","author":"Y Alamanos","year":"2006","journal-title":"Rheumatology (Oxford)."},{"issue":"5","key":"pone.0318747.ref005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00002281-200009000-00007","article-title":"Update in Sjogren syndrome.","volume":"12","author":"RI Fox","year":"2000","journal-title":"Curr Opin Rheumatol."},{"issue":"10061","key":"pone.0318747.ref006","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/S0140-6736(16)30172-6","article-title":"Thyroid cancer.","volume":"388","author":"ME Cabanillas","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"pone.0318747.ref007","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MED.0000000000000359","article-title":"The thyroid cancer epidemic, 2017 perspective.","volume":"24","author":"BR Roman","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"issue":"Suppl 1","key":"pone.0318747.ref008","first-page":"66","article-title":"Risk Factors for Thyroid Cancer: What Do We Know So Far?","volume":"59","author":"T Bogovic Crncic","year":"2020","journal-title":"Acta Clin Croat."},{"issue":"5","key":"pone.0318747.ref009","doi-asserted-by":"crossref","first-page":"103084","DOI":"10.1016\/j.autrev.2022.103084","article-title":"Primary Sjogren\u2019s syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis.","volume":"21","author":"H Zhong","year":"2022","journal-title":"Autoimmun Rev."},{"issue":"12","key":"pone.0318747.ref010","doi-asserted-by":"crossref","first-page":"102987","DOI":"10.1016\/j.autrev.2021.102987","article-title":"Cancer incidence in primary Sjogren\u2019s syndrome: Data from the French hospitalization database","volume":"20","author":"R Goulabchand","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"5","key":"pone.0318747.ref011","first-page":"e8123","article-title":"Peritoneal Carcinomatosis in an Adult With Sjogren\u2019s Syndrome: A Diagnostic Dilemma Revealing a Rare Association With Primary Gastric Adenocarcinoma","volume":"12","author":"D. Findakly","year":"2020","journal-title":"Cureus"},{"key":"pone.0318747.ref012","doi-asserted-by":"crossref","first-page":"106200","DOI":"10.1016\/j.rmed.2020.106200","article-title":"Pulmonary nodules in patients with primary Sjogren\u2019s syndrome: Causes, clinico-radiologic features, and outcomes.","volume":"174","author":"M Casal Moura","year":"2020","journal-title":"Respir Med"},{"issue":"5","key":"pone.0318747.ref013","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/bioinformatics\/btg452","article-title":"Extracting human protein interactions from MEDLINE using a full-sentence parser","volume":"20","author":"N Daraselia","year":"2004","journal-title":"Bioinformatics"},{"issue":"2","key":"pone.0318747.ref014","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis.","volume":"1","author":"M Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"issue":"W1","key":"pone.0318747.ref015","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Z Tang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"pone.0318747.ref016","doi-asserted-by":"crossref","first-page":"39105","DOI":"10.1038\/srep39105","article-title":"Endogenous programmed death ligand-1 restrains the development and onset of Sj\u04e7gren\u2019s syndrome in non-obese diabetic mice","volume":"6","author":"J Zhou","year":"2016","journal-title":"Sci Rep"},{"key":"pone.0318747.ref017","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.imlet.2020.09.001","article-title":"Abnormal membrane-bound and soluble programmed death ligand 2 (PD-L2) expression in systemic lupus erythematosus is associated with disease activity.","volume":"227","author":"M Tong","year":"2020","journal-title":"Immunol Lett"},{"issue":"2","key":"pone.0318747.ref018","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tem.2017.10.008","article-title":"Postsurgical Management of Differentiated Thyroid Cancer in China","volume":"29","author":"WJ Wei","year":"2018","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"pone.0318747.ref019","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4158\/EP-2018-0342","article-title":"Programmed Cell Death-Ligand 1 Overexpression in Thyroid Cancer.","volume":"25","author":"GQ Zhang","year":"2019","journal-title":"Endocr Pract."},{"issue":"11","key":"pone.0318747.ref020","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/art.1780391114","article-title":"Lymphocyte apoptosis and apoptosis-associated gene expression in Sjogren\u2019s syndrome","volume":"39","author":"N Ogawa","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"7","key":"pone.0318747.ref021","first-page":"643","article-title":"[Study of apoptosis in Sjogren\u2019s syndrome].","volume":"45","author":"N Ogawa","year":"1997","journal-title":"Rinsho Byori"},{"issue":"12","key":"pone.0318747.ref022","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1210\/jc.2007-0942","article-title":"Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition","volume":"92","author":"CS Mitsiades","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"pone.0318747.ref023","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12031-016-0823-7","article-title":"Expression of PACAP and PAC1 Receptor in Normal Human Thyroid Gland and in Thyroid Papillary Carcinoma","volume":"60","author":"S Bardosi","year":"2016","journal-title":"J Mol Neurosci"},{"issue":"4","key":"pone.0318747.ref024","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3892\/ijmm.2012.1059","article-title":"The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF\/EGFR in anaplastic thyroid cancer cells","volume":"30","author":"Z Zhang","year":"2012","journal-title":"Int J Mol Med"},{"issue":"1","key":"pone.0318747.ref025","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1210\/jc.2013-2994","article-title":"Laminin-5gamma-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR.","volume":"99","author":"M Garg","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0318747.ref026","article-title":"Nuclear-targeted EGF receptor enhances proliferation and migration of human anaplastic thyroid cancer cells","author":"X Niu","year":"2022","journal-title":"Endokrynol Pol"},{"issue":"2","key":"pone.0318747.ref027","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.exer.2007.11.004","article-title":"Presence of EGF growth factor ligands and their effects on cultured rat conjunctival goblet cell proliferation","volume":"86","author":"J Gu","year":"2008","journal-title":"Exp Eye Res"},{"issue":"1","key":"pone.0318747.ref028","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jtos.2016.09.005","article-title":"Tear Fluid Protein Changes in Dry Eye Syndrome Associated with Rheumatoid Arthritis: A Proteomic Approach.","volume":"15","author":"SV Aluru","year":"2017","journal-title":"Ocul Surf."},{"issue":"13","key":"pone.0318747.ref029","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.7150\/ijms.44723","article-title":"MiR-145 functions as a tumor suppressor in Papillary Thyroid Cancer by inhibiting RAB5C.","volume":"17","author":"W Zhang","year":"2020","journal-title":"Int J Med Sci."},{"key":"pone.0318747.ref030","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12935-019-0943-6","article-title":"miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K\/AKT signaling pathway","volume":"19","author":"TL Zheng","year":"2019","journal-title":"Cancer Cell Int"},{"issue":"5","key":"pone.0318747.ref031","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2174\/1386207324666210125110732","article-title":"Exosomal hsa-miR-129-2 and hsa-miR-889 from a 6-microRNA Signature Might be a Potential Biomarker for Predicting the Prognosis of Papillary Thyroid Carcinoma","volume":"25","author":"Y Xin","year":"2022","journal-title":"Comb Chem High Throughput Screen"},{"key":"pone.0318747.ref032","doi-asserted-by":"crossref","first-page":"685837","DOI":"10.3389\/fimmu.2021.685837","article-title":"Type I Interferon Dependent hsa-miR-145-5p Downregulation Modulates MUC1 and TLR4 Overexpression in Salivary Glands From Sjogren\u2019s Syndrome Patients.","volume":"12","author":"D Jara","year":"2021","journal-title":"Front Immunol."},{"issue":"1","key":"pone.0318747.ref033","doi-asserted-by":"crossref","first-page":"2318814","DOI":"10.1080\/21645515.2024.2318814","article-title":"Hydroxychloroquine is associated with lower seroconversion upon 17DD-Yellow fever primovaccination in patients with primary Sjogren\u2019s syndrome.","volume":"20","author":"KL Libardi Lira Machado","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"pone.0318747.ref034","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25020915","article-title":"Involvement of CCL2 in Salivary Gland Response to Hyperosmolar Stress Related to Sjogren\u2019s Syndrome.","volume":"25","author":"C Chivasso","year":"2024","journal-title":"Int J Mol Sci."},{"issue":"12","key":"pone.0318747.ref035","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.4049\/jimmunol.2101070","article-title":"The IL-33\/ST2 Axis Promotes Primary Sjogren\u2019s Syndrome by Enhancing Salivary Epithelial Cell Activation and Type 1 Immune Response","volume":"208","author":"Y Dong","year":"2022","journal-title":"J Immunol"},{"key":"pone.0318747.ref036","doi-asserted-by":"crossref","first-page":"115974","DOI":"10.1016\/j.biopha.2023.115974","article-title":"Canagliflozin reduces thyroid cancer cells migration in vitro by inhibiting CXCL8 and CCL2: An additional anti-tumor effect of the drug","volume":"170","author":"F Coperchini","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"pone.0318747.ref037","first-page":"1902","article-title":"Expression and Prognostic Value of m6A RNA Methylation-Related Genes in Thyroid Cancer.","volume":"52","author":"H Han","year":"2023","journal-title":"Iran J Public Health"},{"key":"pone.0318747.ref038","doi-asserted-by":"crossref","first-page":"108717","DOI":"10.1016\/j.envint.2024.108717","article-title":"Do PFCAs drive the establishment of thyroid cancer microenvironment? Effects of C6O4, PFOA and PFHxA exposure in two models of human thyroid cells in primary culture.","volume":"187","author":"F Coperchini","year":"2024","journal-title":"Environ Int."},{"key":"pone.0318747.ref039","article-title":"PRDM1 promotes the ferroptosis and immune escape of thyroid cancer by regulating USP15-mediated SELENBP1 deubiquitination","author":"J Ma","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"pone.0318747.ref040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/15412550902751738","article-title":"Alveolar macrophage recruitment and activation by chronic second hand smoke exposure in mice.","volume":"6","author":"PG Woodruff","year":"2009","journal-title":"COPD"},{"key":"pone.0318747.ref041","doi-asserted-by":"crossref","first-page":"683623","DOI":"10.3389\/fimmu.2021.683623","article-title":"Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjogren\u2019s Syndrome-Related Lymphoma?","volume":"12","author":"A Nezos","year":"2021","journal-title":"Front Immunol."},{"key":"pone.0318747.ref042","doi-asserted-by":"crossref","first-page":"1380495","DOI":"10.3389\/fgene.2024.1380495","article-title":"Polymorphism Pro64His within galectin-3 has functional consequences at proteome level in thyroid cells","volume":"15","author":"R Silvestri","year":"2024","journal-title":"Front Genet"},{"key":"pone.0318747.ref043","doi-asserted-by":"crossref","first-page":"155319","DOI":"10.1016\/j.prp.2024.155319","article-title":"BRAF mutation, selected miRNAs and genes expression in primary papillary thyroid carcinomas and local lymph node metastases","volume":"258","author":"D Kalfert","year":"2024","journal-title":"Pathol Res Pract"},{"key":"pone.0318747.ref044","doi-asserted-by":"crossref","first-page":"151973","DOI":"10.1016\/j.anndiagpath.2022.151973","article-title":"Evaluation of Lipocalin-2 and Twist expression in thyroid cancers and its relationship with epithelial mesenchymal transition","volume":"59","author":"P Celepli","year":"2022","journal-title":"Ann Diagn Pathol"},{"issue":"2","key":"pone.0318747.ref045","doi-asserted-by":"crossref","first-page":"694","DOI":"10.21037\/tcr-20-2866","article-title":"Identification of candidate genes associated with papillary thyroid carcinoma pathogenesis and progression by weighted gene co-expression network analysis","volume":"10","author":"X Chen","year":"2021","journal-title":"Transl Cancer Res"},{"issue":"1","key":"pone.0318747.ref046","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41389-023-00496-w","article-title":"NF-kappaB signaling activation and roles in thyroid cancers: implication of MAP3K14\/NIK.","volume":"12","author":"F Cormier","year":"2023","journal-title":"Oncogenesis"},{"issue":"12","key":"pone.0318747.ref047","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124365","article-title":"Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer.","volume":"21","author":"GS Santiago-Sanchez","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"19","key":"pone.0318747.ref048","article-title":"A Temporal Comparative RNA Transcriptome Profile of the Annexin Gene Family in the Salivary versus Lacrimal Glands of the Sjogren\u2019s Syndrome-Susceptible C57BL\/6.NOD-Aec1Aec2 Mouse.","volume":"23","author":"AB Peck","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"11","key":"pone.0318747.ref049","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1002\/hed.27518","article-title":"Increased prevalences of head and neck cancers in patients with Sjogren\u2019s syndrome.","volume":"45","author":"TH Yang","year":"2023","journal-title":"Head Neck"},{"issue":"5","key":"pone.0318747.ref050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/dna.2023.0374","article-title":"PANoptosis Features, a Humanized NSG Murine Model of Sjogren\u2019s Syndrome","volume":"43","author":"Y Yang","year":"2024","journal-title":"DNA Cell Biol"},{"key":"pone.0318747.ref051","doi-asserted-by":"crossref","first-page":"109916","DOI":"10.1016\/j.exer.2024.109916","article-title":"Experimental interventions attenuate a conjunctival epidermal metaplasia model","volume":"243","author":"Y Takezawa","year":"2024","journal-title":"Exp Eye Res"},{"key":"pone.0318747.ref052","doi-asserted-by":"crossref","first-page":"154095","DOI":"10.1016\/j.prp.2022.154095","article-title":"Circ_0027446 induces CLDN1 expression to promote papillary thyroid cancer cell malignancy by binding to miR-129-5p.","volume":"238","author":"H Zhang","year":"2022","journal-title":"Pathol Res Pract."},{"issue":"2","key":"pone.0318747.ref053","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/1878-0261.12615","article-title":"Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin","volume":"14","author":"A Piontek","year":"2020","journal-title":"Mol Oncol"},{"issue":"4","key":"pone.0318747.ref054","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/pin.13420","article-title":"Carcinoma showing thymus-like elements (CASTLE) with amyloid deposition in the parotid gland.","volume":"74","author":"M Hamada","year":"2024","journal-title":"Pathol Int"},{"issue":"5","key":"pone.0318747.ref055","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/ar2833","article-title":"Increased levels of circulating microparticles in primary Sjogren\u2019s syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity","volume":"11","author":"J Sellam","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"pone.0318747.ref056","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s10067-022-06098-y","article-title":"Altered levels of circulating CD8(+)CXCR5(+)PD-1(+)T follicular cytotoxic cells in primary Sjogren\u2019s syndrome.","volume":"41","author":"X Zhai","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"11","key":"pone.0318747.ref057","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.autrev.2013.06.012","article-title":"18F-fluorodeoxyglucose positron emission tomography\/computer tomography as an objective tool for assessing disease activity in Sjogren\u2019s syndrome","volume":"12","author":"C Cohen","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"7","key":"pone.0318747.ref058","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/rheumatology\/37.7.779","article-title":"Chemokine expression and leucocyte infiltration in Sjogren\u2019s syndrome","volume":"37","author":"C Cuello","year":"1998","journal-title":"Br J Rheumatol"},{"issue":"7","key":"pone.0318747.ref059","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39629","article-title":"Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3-Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon-Positive Primary Sjogren\u2019s Syndrome.","volume":"68","author":"NI Maria","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"pone.0318747.ref060","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3389\/fimmu.2020.01423","article-title":"From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment.","volume":"11","author":"S Kloss","year":"2020","journal-title":"Front Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0318747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T18:27:36Z","timestamp":1739212056000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0318747"}},"subtitle":[],"editor":[{"given":"Vahid","family":"Mansouri","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":60,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0318747","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]}}}